References
- Brown AL, Middleton G, MacVicar AD, Husband JE. Ti-weighted magnetic resonance imaging in breast cancer vertebral metastases: changes on treatment and correla-tion with response to therapy. Clin Radiol 1998;53: 493–501.
- Byun WM, Shin SO, Chang Y, et al. Diffusion-weighted MR imaging of metastatic disease of the spine: assess-ment of response to therapy. AJNR 2002;23:906–12.
- Ciray I, Lindman H, Astrom KG, Bergh J, Ahlstrom KB. Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging. Acta Radiol 2001;42:198–206.
- Hawighorst H, Libicher M, Knopp MV, et al. Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and quantitative dynamic MRI. J Magn Reson Imag 1999;10:286–94.
- Hortobagyi GN. Novel approaches to the management of bone metastases in patients with breast cancer. Semin Oncol 2002;29:134–44.
- Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101–10.
- Shapeero LG, Vanel D. Imaging evaluation of the response of high-grade osteosarcoma and Ewing sarcoma to chemotherapy with emphasis on dynamic contrast-enhanced magnetic resonance imaging. Semin Musculos-kelet Radiol 2000;4:137–46.
- Taylor JS, Reddick WE. Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI. Adv Drug Deliv Rev 2000; 41:91–110.
- Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imag 1999;10:903–7.